Emea Solid Oral Nutraceutical Excipient Market Trends

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

EMEA Solid Oral Nutraceutical Excipient Market Size, Share, and Trends Analysis Report Trends

  • Pharmaceutical
  • Dec 2023
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

“Rising Demand for Clean Label and Plant-Based Excipients”

  • A significant and accelerating trend in the EMEA solid oral nutraceutical excipient market is the growing preference for clean label and plant-based excipients, driven by heightened consumer awareness regarding ingredient transparency, sustainability, and ethical sourcing. This shift is reshaping product development across both mature and emerging markets in the region
  • For instance, leading manufacturers like Roquette Frères and DFE Pharma are expanding their offerings to include natural and botanical binders, fillers, and disintegrants that meet vegan, allergen-free, and non-GMO standards. These clean label excipients support nutraceutical brands in making desirable product claims that align with consumer health values
  • The clean label movement is especially strong in Europe, where regulatory frameworks such as EFSA guidelines and increasing demand for minimally processed ingredients are driving reformulation efforts. In parallel, plant-based trends are gaining ground in the Middle East and Africa, aligning with lifestyle changes and rising interest in natural wellness solutions
  • These excipients not only satisfy growing consumer expectations but also contribute to enhanced marketability of finished products by enabling claims such as “no artificial additives” and “naturally derived.” As a result, manufacturers are prioritizing clean excipient sourcing to differentiate their products and expand market reach
  • This trend toward natural, transparent, and sustainable excipient solutions is creating new innovation pathways and competitive advantages for companies operating in the EMEA nutraceutical space